Archives

Vos collègues souhaitent rejoindre notre communauté et s'abonner à notre newsletter ? L'inscription se fait ici.

A la Une

Dans le cadre de la Stratégie décennale de lutte contre les cancers 2021-2030, l'ITMO Cancer d'Aviesan programme des appels à projets ou à candidatures pour l'année 2024, dont la gestion opérationnelle est confiée à l'Inserm.

Toutes les informations ici.

APPELS EN COURS

CLÔTURE IMMINENTE MCMP - Date limite de candidature : 8 Février 2024 à 17h.

FRFT-Doc - Date limite de candidature : 22 Février 2024 à 17h.

Nouvelles annonces

CLÔTURE IMMINENTE

Le Prix Paul-Gabay (Comité du Val-d'Oise de La Ligue contre le cancer) est destiné à aider ou à récompenser des travaux consacrés à l’étude des cancers professionnels (mécanismes de la carcinogenèse, prévention, dépistage). Les travaux soumis peuvent concerner des approches expérimentales (visant à explorer le mécanisme d’action ou l’effet cancérogène d’agents du milieu professionnel), épidémiologiques ou être en rapport avec des actions de prévention (programmes spécifiques d’évaluation des expositions), de dépistage ou de prise en charge sur le plan médico-social.

Date limite de candidature : 30 Janvier 2024.

Consulter l'AAC.

Plus d'infos.

CLOSING SOON

The Call for proposals "Nano and advanced technologies for disease prevention, diagnostic and therapy (NANOTECMEC)", funded by the European Union in the frame of the ERA4Health patnership, will aim to:

• Support translational research projects that combine innovative approaches in the field of nanomedicine;
• Encourage and enable transnational collaboration between academic research and clinical/public health research or R&D activities from industrial enterprises.

Deadline for pre-proposals submission: January 30^th 2024.

See the Call.

More information.

CLÔTURE IMMINENTE

MATWIN propose le programme accélérateur GROW, en collaboration avec le Paris-Saclay Cancer Cluster.

Date limite de candidature : 31 Janvier 2024.

Plus d'infos.

CLÔTURE IMMINENTE

La Fondation ARC soutient chaque année des projets de recherche ambitieux et originaux dans le cadre de ses appels à projets « Aides individuelles Jeunes chercheurs ».

Date limite de soumission des candidatures (session printemps 2024) : 8 Février 2024 à 15h.

Master 2 recherche ou doctorat en sciences (profils médicaux)

Texte de l'AAC.

4^e année de thèse

Texte de l'AAC.

Post-doctorat en France

Texte de l'AAC.

Les contrats « Postes d'Accueil » de l'Inserm permettent à de jeunes médecins, pharmaciens, odontologistes ou vétérinaires d'effectuer 2 ou 3 années à temps plein dans une unité de recherche de l'Inserm pour réaliser une thèse de sciences.

Date limite de candidature : 19 Février 2024 à 17h.

Consulter le guide du candidat.

Plus d'infos.

APPEL OUVERT

L'INCa lance son appel à projets de recherche High Risk-High Gain en cancérologie pédiatrique.

Date limite de soumission des candidatures : 20 Février 2024 à 16h.

Consulter l'AAP.

Plus d'infos.

La Fondation ARC et la Société française du cancer soutiennent de jeunes chercheurs cliniciens souhaitant se former à la recherche dans un laboratoire d’excellence à l’international.

Date limite de candidature : 22 Février 2024 à 15h.

Consulter l'AAC.

Plus d'infos.

SAVE THE DATE

L’Agence pour la recherche médicale et le développement du Japon et l'INCa lancent l'édition 2024 de l’appel à projets de recherche Adopting Sustainable Partnerships for an Innovative Research Ecosystem. Ce programme encourage la création de consortiums internationaux via l’octroi d’un financement principal de l’AMED, une partie importante des subventions étant dédiée à la mobilité internationale.

Ouverture : Mars - Mai 2024.

Plus d'infos.

January 31^st 2024, 14:00-17:15 CET, Brussels & Virtual

Three years after the adoption of Europe’s Beating Cancer Plan, Stella Kyriakides, European Commissioner for Health and Food Safety, will host a high-level event to take stock of Europe’s efforts to improve the lives of everyone touched by cancer and to take the lead in the fight against this disease.

More information.

February 15^th 2024, 15:00 CET

EACR and  10x Genomics will welcome Michael Ritter (University Hospital of Heidelberg) who will talk about using spatial transcriptomics to help overcome limitations in the diagnosis and treatment of glioblastoma.

More information.

LAST DAYS FOR REGISTRATION

February 26^th - 28^th 2024, Paris

The European Society for Medical Oncology Targeted Anticancer Therapies Congress will be dedicated to improving the conduct of early phase clinical trials in oncology by providing the latest scientific breakthroughs as well as workshops and educational reviews on pre-clinical and early clinical data.

Deadline for registration: February 7^th 2024.

Programme.

More information.

LAST DAYS FOR REGISTRATION

February 27^th - 29^th 2024, Dublin (Ireland)

The European Association for Cancer Research and American Association for Cancer Research, in collaboration with the Irish Association for Cancer Research, organise a joint conference which will focus on bringing the latest discoveries from basic science to the clinic. The forum will highlight the latest cutting-edge advances in the understanding of the genomics, epigenetics and molecular pathways involved in the development of pre-cancerous and cancerous lesions and/or in cancer response to therapy.

Deadline for registration: January 26^th 2024.

Programme.

More information.

LAST DAYS FOR ON-SITE ATTENDING REGISTRATION

March 12^th - 15^th 2024, Heidelberg (Germany) & Virtual

The aim of this symposium organised by the European Molecular Biology Organisation (EMBO) and the European Molecular Biology Laboratory (EMBL) is to catalyse synergistic interactions between AI researchers in different subfields of biology, by exploring shared theoretical approaches, cross-domain experiments, and data integration, as well as shared topics in dissemination of tools and collaboration with experimental labs.

Deadline for registration: January 30^th 2024 (on-site attending) & March 5^th 2024 (virtual attending).

Pre-programme & More information.

19 Mars 2024, Paris

L’INCa, la Ligue contre le cancer et la Fondation ARC organisent un séminaire de restitution autour des 3 projets soutenus, entre 2016 et 2023, dans le cadre du Programme d’actions intégrées de recherche consacré aux cancers de l’enfant, de l’adolescent et du jeune adulte.

Inscription.

Programme.

Plus d'infos.

SAVE THE DATE

May 15^th - 17^th 2024, Paris

The Institut Curie will organise its 1^st International Symposium "From Basic Science to Cancer Research".

More information.

April 8^th - 10^th 2024, Paris

This international course "Radiomics: Theory & Practice", organised by the Institut Curie/PSL University Training office, will aim to explain what radiomics is, define best practices and teach how to use the free LIFEx software to analyze images and carry out radiomic studies.

Deadline for registration: March 1^st 2024.

Programme.

More information.

LAST DAYS FOR REGISTRATION

April 23^rd - 26^th 2024, Singapore

The core objective of this European Molecular Biology Organisation (EMBO) Workshop is to bring together outstanding researchers, from all around the world, at all stages in the field of epigenetics/chromatin biology with a focus on cancer for the exchange of ideas and information.

Deadline for abstract submission: February 1^st 2024.

Deadline for registration: February 1^st 2024.

More information.

L'équipe "Génétique, épigénétique et stratégies thérapeutiques des cancers rénaux et cancers rares" au sein de l'Institut de génétique et de biologie moléculaire et cellulaire recherche (CNRS UMR7104/Inserm U1258, Illkirch) un(e) assistant(e) ingénieur(e).

Consulter l'offre.

The team "Génétique, épigénétique et stratégies thérapeutiques des cancers rénaux et cancers rares" at the Institut de génétique et de biologie moléculaire et cellulaire (CNRS UMR7104/Inserm U1258, Illkirch) opened 2 post-doc positions in functional genomics of rare kidney cancers. 

Deadline for application: March 1^st 2024.

See the Call.

Et toujours d'actualité

La Ligue contre le cancer publie le calendrier de ses appels à projets et à candidatures pour l'année 2024.

4^e année de thèse

Date limite de candidature : 12 Février 2024.

Consulter l'AAC.

Mobilité cliniciens

Date limite de candidature : 12 Février 2024.

Consulter l'AAC.

Douleurs et cancers

Date limite de soumission des lettres d'intention : 12 Février 2024.

Consulter l'AAP.

Enfants, adolescents et cancer

Date limite de soumission des lettres d'intention : 12 Février 2024.

Consulter l'AAP.

Recherche clinique

Date limite de soumission des lettres d'intention : 12 Février 2024.

Consulter l'AAP.

Équipes labellisées 2025

Date limite de soumission des lettres d'intention : 21 Février 2024.

Consulter l'AAP.

Colloques (1^re session)

Date limite de candidature : 27 Mars 2024.

Consulter l'AAC.

Thérapies cellulaires innovantes

Date limite de soumission des lettres d'intention (ouverture le 15 Janvier 2024) : 15 Avril 2024.

Consulter l'AAP.

Doctorats

Date limite de candidature (ouverture le 10 Mai 2024) : 24 Juin 2024.

Consulter l'AAC.

This Call for proposals from the Fondation ARC wishes to allow the implantation in France of new scientific leader that will establish his/her team and carry out ambitious research in oncology.

Deadline for application: February 15^th 2024, 3:00 PM.

See the Call.

More information.

La Fondation Simone-et-Cino-Del-Duca de l’Institut de France décerne chaque année, alternativement au titre des disciplines relevant des deux divisions de l’Académie des sciences, un Grand prix scientifique et des subventions scientifiques.

Grand prix scientifique 2024 : "Voir le vivant"

Date limite de soumission des candidatures : 15 Février 2024.

Consulter l'AAC et le règlement.

Plus d'infos.

Subventions scientifiques

Date limite de soumission des candidatures : 15 Février 2024.

Consulter l'AAC et le règlement.

Plus d'infos.

L’objectif de l’appel à projets "Signatures en immunothérapie" de la Fondation ARC est de favoriser l’identification de signatures permettant de prédire la réponse d'une tumeur à un traitement par immunothérapie, et donc de guider la décision thérapeutique.

Date limite de soumission des candidatures : 6 Mars 2024 à midi.

Consulter l'AAP.

Plus d'infos.

La Fondation ARC renouvelle son appel à projets « Cancer & Vieillissement » afin de soutenir des projets de recherche translationnelle consacrés à la compréhension des spécificités de la biologie des tumeurs chez les patients âgés.

Date limite de soumission des candidatures : 12 Mars 2024 à 15h.

Consulter l'AAP.

Plus d'infos.

The ERC Proof of Concept Grants aim at facilitating exploration of the commercial and social innovation potential of ERC funded research and are therefore available only to Principal Investigators whose proposals draw substantially on their ERC funded research.

Deadlines for application: March 14^th 2024 & September 17^th 2024, 17:00 (Brussels time)

More information.

Dans le cadre du programme généraliste "Espoirs de la recherche", la Fondation pour la recherche médicale lance son appel à candidatures "Aides individuelles" pour l'année 2024.

Consulter l'AAC.

Plus d'infos.

Poste de thèse pour internes et assistants

Date limite de candidature (ouverture le 9 Février 2024) : 14 Mars 2024.

Aide au retour en France

Ouverture de l'appel : 24 Avril - 23 Mai 2024.

Post-doctorat en France

Ouverture de l'appel : 24 Avril - 23 Mai 2024.

Dans le cadre du plan Innovation Santé 2030, l'Agence nationale de la recherche a lancé son appel à candidature "Chaire d’excellence en biologie/santé". Cette mesure a pour objectif d’offrir à des chercheurs de premier plan et de toutes origines des financements conséquents pour mener en France de nouveaux projets d’envergure.

Date limite de soumission des lettres d'intention (levée 3) : 23 Avril 2024 à 11h CEST.

Consulter l'AAC.

Plus d'infos.

SAVE THE DATE

L’Inserm ouvre en 2024 10 chaires, parmi lesquelles 4 concernent, en tout ou partie, la recherche sur le cancer.

Computational Modeling for Multi-Omics Data - Unité d'accueil : CRCM (Institut Paoli-Calmettes/CNRS/Aix-Marseille Université/Inserm U1068).

Consulter l'AAP.

Epitranscriptomics and Cancer Adaptation - Unité d'accueil : IRCM (Université de Montpellier/Inserm U1194).

Consulter l'AAP.

Bioengineering for Therapeutics - Unité d'accueil : Université de Nantes/Inserm U1089, U1229, U1307.

Consulter l'AAP.

Identification of Dysregulated Embryonal Programs in Pediatric Cancers - Unité d'accueil :  Institut Curie/Université PSL/Inserm U830, Paris.

Consulter l'AAP.

Processus & Calendrier.

13 Février 2024, de 11h à midi

Le prochain rendez-vous du programme LORIER (Organisation pour une recherche Inserm éthique et responsable) sera consacré au thème : "La science ouverte : pourquoi et comment ?", avec Michel Pohl.

February 13^th - 14^th 2024, Virtual

This conference organised by the European Association for Cancer Research (EACR) will focus on basic mechanisms controlling cancer cell signaling circuits at the epigenome, transcriptome, proteome and phosphoproteome levels. The talks will also focus on therapeutic targeting of cancer cell signaling circuits by conventional and emerging pharmacological strategies.

Programme.

More information.

March 4^th - 6^th 2024, Bordeaux

This workshop organised by the Institute for Philosophy in Biology and Medicine will focus on two topics:

• The role of the microbiota in cancer development and dissemination, a question that attracts increasing attention but remains challenging to address;
• The metastasis, which is considered as a major challenge for cancer treatment and a leading cause of cancer death, and for which innovative conceptual and theoretical frameworks are needed.

Programme & More information.

March 5^th - 6^th 2024, Paris

This symposium will focus on the latest innovations and concepts in basic glycosciences and their applications to biomedicine.

Registration.

Preliminary Programme.

March 19^th - 21^st 2024, Bergamo (Italy)

This meeting organised by EACR will cover the latest breakthroughs on multiple aspects of the tumour microenvironment, including the intricate interactions of cancer cells with the immune system and with specific stromal cells in multiple organs. Novel insights into tumour-host interactions including changes in metabolism, the nervous system and response to therapy will be highlighted.

Deadline for registration: February 19^th 2024.

Programme.

More information.

April 30^th - May 2^nd 2024, Bergamo (Italy)

This conference organised by the European Association for Cancer Research (EACR) will cover the following domains:

• Machine learning and artificial intelligence to analyse and integrate multiomic data;
• Genomes and transcriptomes of cancers at single cell resolution;
• Cell tracking to monitor evolution and plasticity;
• Cancer evolution and immune evasion;
• Interpreting the cancer genome;
• Cancer epigenetics;
• Identification of (neo)antigenic landscape and specific antitumor T-cell response in human cancers;
• Spatial and 3D analysis of tumors at molecularly annotated single cell resolution.

Deadline for abstract submission: February 26^th 2024.

Deadline for registration: March 25^th 2024.

Programme.

More information.

May 15^th - 17^th 2024, Mainz (Germany)

This congress organised by the Association for Cancer Immunotherapy will cover preclinical to clinical developments on thetopics of cellular therapy, vaccines, immunomodulation, immunometabolism, tumor microenvironment, and immunobioinformatics, covering a wide range of areas in cancer immunotherapy.

Deadline for abstract submission: March 9^th 2024.

Deadline for registration: March 23^rd 2024.

Programme (coming soon).

More information.

SAVE THE DATE

16 Mai 2024, Paris

Cet événement organisé par la Fondation ARC sera ouvert à tous les membres de la communauté scientifique et médicale, française et internationale, s'intéressant aux spécificités des cancers chez les patients âgés.

Plus d'infos (à venir).

May 16^th - 17^th 2024, Bordeaux

Matwin will organise the 9^th edition of its European Partnering Convention entirely dedicated to open innovation in oncology: A two-day partnering convention combining conferences, collaborative sessions, projects’ pitches, one-to-one prescheduled business meetings, etc.

Deadline for application: February 28^th 2024.

Registration.

Programme.

More information.

May 29^th - 31^th 2024, Ajaccio

The 5^th meeting of the SUNRiSE Network will be dedicated to the theme 'Heterogeneity and Plasticity in Cancer', with the most recent insights in the CSC field such as:

• Metabolic plasticity;
• CSC maintenance;
• Understanding and targeting tumor heterogeneity;
• Deciphering the interplay between CSC and tumor microenvironment.

Deadline for early bird registration: February 24^th 2024.

Programme & More Information.

June 10^th - 13^th 2024, Rotterdam (Netherlands)

The 2024 Annual Congress of the European Association for Cancer Research (EACR) is a four day congress dedicated to basic, preclinical and translational cancer research across a wide breadth of topics. It will highlight the latest research and bring together the cancer research community to inspire innovation and build knowledge, connections and collaborations.

Deadline for abstract submission: March 4^th 2024.

Deadline for early rate registration: April 29^th 2024.

Programme.

More information.

September 30^th - October 3^rd 2024, Heidelberg (Germany) & Virtual

This symposium organised by the European Molecular Biology Organisation (EMBO) and the European Molecular Biology Laboratory (EMBL) will cover emerging key concepts of latent metastasis and dissemination of tumor cells. Topics will address:

• Metastasis initiating cells, circulating tumour cells;
• Motility and invasion;
• Transcriptional and epigenetic control of metastasis;
• Metastasis heterogeneity, empithelial-mesenchymal transition and plasticity;
• Metastasis signalling and latency;
• Metastasis imaging, tumour microenvironment and immune evasion.

Deadline for registration: August 19^th 2024 (on-site attending) & September 23^rd 2024 (virtual attending).

More information.

October 8^th - 10^th 2024, Bilbao (Spain)

The EACR Conference on Cancer Metabolism will gather top experts to discuss the metabolic alterations in tumours and how this can be exploited to treat cancer.

Deadline for abstract submission: August 5^th 2024.

Deadline for registration: September 9^th 2024.

Programme.

More information.

November 12^th - 14^th 2024, Lyon

This European Association for Cancer Research (EACR) Conference will provide a comprehensive overview of liquid biopsies in cancer, with the following topics to be covered:

• Implementation of liquid biopsy in clinical trials; 
• Applications for CTCs;
• Basic biology for biomarker discovery;
• New techniques enhancing liquid biopsy;
• Integration of multiple blood-based analytes for multimodal biomarkers;
• Artificial Intelligence applied to liquid biopsy.

Deadline for abstract submission: September 16^th 2024.

Deadline for registration: October 14^th 2024.

Programme.

More information.

January 30^th - 31^st 2024, Virtual

The European Association for Cancer Research (EACR), in partnership with the European Molecular Biology Organisation (EMBO), launches a virtual conference for those working in cancer research in an academic environment who are considering at some point in the future taking their research private by starting their own company.

Programme.

More information.

February 27^th - March 1^st 2024, Heidelberg (Germany)

This practical course organised by the European Molecular Biology Organisation (EMBO) will cover the following topics:

• Multimodal data integration;
• Multi-omics factor analysis;
• Statistical analysis;
• Spatialresolution;
• Single-cell data.

Preliminary programme.

More information.

March 13^th - 20^th 2024, Paris

The aim of this Course 'Epigenetics:From nuclear organization to development in healthy and diseased states' organised by the Institut Curie/PSL University Training office is to provide an overview of epigenetic mechanisms and their links to gene expression and chromatin dynamics in different systems. Links between the disruption of nuclear functions and the development of human pathologies will be discussed. This year, focus will be on reprogramming aspects during development and in disease with a special emphasis on cancer.

Programme.

More information.

April 22^nd - 26^th 2024, Paris

The objective of this Course organised by the Institut Curie/PSL University Training office is to expose PhD and Master students coming from European laboratories to cutting edge concepts in the field of cell biology.

Deadline for registration: February 22^nd 2024.

More information.

May 3^rd - 6^th 2024, Düsseldorf (Germany)

This workshop organised by the European Molecular Biology Organisation (EMBO) will be dedicated to the theme 'Intercepting childhood blood cancer: from single cells to malignant clones'.

Deadline for abstract submission: February 15^th 2024.

Deadline for registration: February 15^th 2024.

Programme & More information.

May 22^nd - 29^th 2024, Paris

This international course, organised by the Institut Curie/PSL University Training office, will explore the versatility of non-genic DNA elements and non-coding RNAs across a spectrum of cellular processes, in humans and model organisms, and their implication in physiology and disease.

Deadline for registration: March 3^rd 2024.

Programme.

More information.

May 29^th - 31^st 2024, Rimini (Italy)

This worshop organised by the European Molecular Biology Organisation (EMBO) will cover the following topics:

• Tumour evolution;
• Chromatin and description;
• Cell plasticity;
• Tumour heterogeneity;
• Epigenetics and gene regulation.

Deadline for abstract submission: April 15^th 2024

Deadline for early bird registration: March 15^th 2024.

Programme & More information.

August 18^th - 26^th 2024, Spetses (Greece)

This Lecture Course organised by the European Molecular Biology Organisation (EMBO) and the Federation of European Biochemical Societies (FEBS) will cover the following topics:

• Signaling by various pathways (PI3K, WNT, RAS/RAF);
• DNA damage and protein degradation signaling;
• Consequences of pathway deregulation for cellular processes like metabolism and damage repair;
• Application or translation of this knowledge into the clinic.

Deadline for abstract submission: April 1^st 2024.

Deadline for registration: April 1^st 2024.

Programme & More information.

SAVE THE DATE

September 1^st - 3^rd 2024, London (UK) & Virtual

More information (coming soon).

SAVE THE DATE

October 23^rd - 25^th 2024, Rome (Italy)

More information (coming soon).

SAVE THE DATE

November 17^th - 22^nd 2024, Heidelberg (Germany)

This course organised by the European Molecular Biology Organisation (EMBO) will update the participants about different case-by-case models starting with the basic science, and how to best explore these models with accurate data acquisition and reporting.The topics chosen are:

• Immune reconstitution;
• Oncology;
• Immuno-Oncology;
• Regenerative Medicine;
• Infections.

Pre-programme & More information.

A post-doctoral position (30 months) at the interface between Cancerology, Immunology and Vascular Biology is available in the 'Equipe Labellisée LIGUE 2023' (LabEx TOUCAN, IPBS, Toulouse).

See the Call.

The Centre de recherche Saint-Antoine in Paris is seeking a post-doc scientist with strong background in liver physiopathology, ideally in cholangiocarcinoma, and a strong interest in interdisciplinary research.

See the Call.

More information.

L'équipe Genomics and Development of Childhood Cancers de l'unité "Cancer, hétérogénéité, instabilité et plasticité" (Institut Curie/Université PSL/Inserm U830) recrute :

• un(e) ingénieur(e) en bioinformatique

Consulter l'offre.

• un(e) post-doc en bioinformatique/génomique

Consulter l'offre.

Le groupe Mécanismes moléculaires des pathologies de l'hématopoïèse et biothérapies (Institut Imagine) recrute un.e assistant.e ingénieur.e ou ingénieur.e d'étude pour travailler sur la fonction d'un gène lié à l'apoptose dans deux maladies hématopoïétiques rares : le syndrome lymphoprolifératif auto-immun et la mastocytose.

Consulter l'offre.

The team Cancer Cell Signalling in the Centre de recherche en biologie cellulaire de Montpellier is looking for a young scientist to work on a new oncogenic mechanism in hepatoellular carcinoma.

See the Call.

Contact.

A post-doc position in onco-immunology is available in the Tumor Microenvironment group of the Inserm Unit 1109 in Strasbourg.

See the Call.

Contact.